Falcon Wealth Planning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$520K Sell
4,045
-381
-9% -$44.6K 0.03% 141
2026
Q1
$533K Buy
4,426
+65
+1% +$7.5K 0.04% 129
2025
Q4
$459K Buy
4,361
+1,179
+37% +$111K 0.04% 126
2025
Q3
$267K Buy
3,182
+397
+14% +$32.7K 0.02% 159
2025
Q2
$220K Sell
2,785
-235
-8% -$18.7K 0.02% 165
2025
Q1
$271K Buy
3,020
+318
+12% +$29.7K 0.03% 146
2024
Q4
$269K Sell
2,702
-65
-2% -$6.7K 0.03% 139
2024
Q3
$314K Buy
2,767
+194
+8% +$23K 0.04% 119
2024
Q2
$319K Buy
2,573
+161
+7% +$20.7K 0.04% 103
2024
Q1
$318K Buy
2,412
+34
+1% +$4.19K 0.05% 108
2023
Q4
$259K Buy
+2,378
New +$247K 0.05% 109

Other funds holding MRK

Falcon Wealth Planning's MRK Position: Q2 2026 in Review

Falcon Wealth Planning reduced its Merck (MRK) stake by 8.6% in Q2 2026, selling an estimated $44.6K and leaving 4,045 shares worth $520K. The position accounts for 0.03% of the portfolio, ranked #141.

Falcon Wealth Planning first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $533K in Q1 2026. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Falcon Wealth Planning held 4,045 shares of Merck worth $520K as of Q2 2026.
  • Falcon Wealth Planning sold 381 Merck shares in Q2 2026, an estimated $44.6K.
  • Merck made up 0.03% of Falcon Wealth Planning's portfolio in Q2 2026, its #141 holding.
  • Falcon Wealth Planning first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Falcon Wealth Planning's Merck position peaked at $533K in Q1 2026.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Falcon Wealth Planning's 13F filing for Q2 2026, filed 13 Jul 2026.